Form 4 for ALT Altimmune, Inc.
Accepted 2023-08-02 00:00:00 ET · period of report 2023-07-31 · accession 0001104659-23-086904 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-02 | 2023-07-31 | ALT | Roberts M Scot | CSO | A - Grant | $2.81 | +568 | 20.4K | +3% | +$1,596 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2023-07-31 | A | A | 568 | $2.81 | 20,424 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2023. |